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Dual-energy CT with tin filter technology for the discrimination
of renal lesion proxies containing blood, protein, and
contrast-agent. An experimental phantom study
Abstract
PURPOSE: To differentiate proxy renal cystic lesions containing protein, blood, iodine contrast or
saline solutions using dual-energy CT (DECT) equipped with a new tin filter technology (TFT).
MATERIALS AND METHODS: 70 proxies (saline, protein, blood and contrast agent) were placed in
unenhanced and contrast-enhanced kidney phantoms. DECT was performed at 80/140 kV with and
without tin filtering. Two readers measured the CT attenuation values in all proxies twice. An 80/140
kV ratio was calculated. RESULTS: All intra- and interobserver agreements were excellent (r =
0.93-0.97; p < 0.001). All CT attenuation values were significantly higher in the enhanced than in the
unenhanced setting (p < 0.05; average increase, 12.5 +/- 3.6HU), while the ratios remained similar
(each, p > 0.05). The CT attenuation of protein, blood and contrast agent solution differed significantly
with tin filtering (p < 0.01-0.05). Significant differences were found between the ratios of protein and
blood compared to contrast medium solution (each, p < 0.05) and between the ratios of protein and
blood in both phantoms with tin filtering (each, p < 0.05). CONCLUSION: DECT allows discrimination
between a proxy renal lesion containing contrast agent and lesions containing protein and blood through
their different attenuation at 80 kV and 140 kV. Further discrimination between protein and blood
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 Abstract  
 
Purpose: To differentiate proxy renal cystic lesions containing protein, blood, iodine 
contrast or saline solutions using dual-energy CT (DECT) equipped with a new tin 
filter technology (TFT).  
Materials and Methods: 70 proxies (saline, protein, blood and contrast agent) were 
placed in unenhanced and contrast-enhanced kidney phantoms. DECT was 
performed at 80/140kV with and without tin filtering. Two readers measured the CT 
attenuation values in all proxies twice. An 80/140kV ratio was calculated. 
Results: All intra- and interobserver agreements were excellent (r=0.93-0.97; 
p<0.001). All CT attenuation values were significantly higher in the enhanced than in 
the unenhanced setting (p<0.05; average increase, 12.5±3.6HU), while the ratios 
remained similar (each, p>0.05). The CT attenuation of protein, blood and contrast 
agent solution differed significantly with tin filtering (p<0.01-0.05). Significant 
differences were found between the ratios of protein and blood compared to contrast 
medium solution (each, p<0.05) and between the ratios of protein and blood in both 
phantoms with tin filtering (each, p<0.05).  
Conclusion:  DECT allows discrimination between a proxy renal lesion containing 
contrast agent and lesions containing protein and blood through their different 
attenuation at 80kV and 140kV. Further discrimination between protein and blood 
containing proxies is possible when using a tin filter. 
 
Key words: Dual-Energy CT, DECT, Renal Cysts, Kidney lesions, tin filter. 
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 Introduction 
 Cystic renal lesions are estimated to be present in 20 – 40% of the population 
and represent frequent, most of the times incidental findings in abdominal computed 
tomography (CT) examinations [1]. Alongside the cyst’s diameter, wall thickness, 
presence of septa and contrast enhancing components, the measurement of the 
mean CT attenuation value (in Hounsfield Units, HU) of the cysts’ content on 
unenhanced CT images as well as the assessment of its attenuation pattern after the 
administration of intravenous contrast media are supporting the radiologists to 
classify cystic renal lesions [2]. Cysts surrounded by thin, smooth walls and mean CT 
attenuation values between 0 – 20 HU are considered simple benign cysts if they do 
not enhance after the application of contrast agents [2-4]. These cysts are classified 
category I by Bosniak [1]. Homogeneous cysts with mean CT attenuation values 
between 40 – 90 HU on unenhanced CT images are considered hyperattenuating 
cysts if they are also enclosed by thin, smooth walls and do not enhance after 
contrast agent administration [3]. Cysts containing blood (i.e. haemorrhagic cysts) or 
protein (i.e. proteinaceous cysts) also represent as hyperattenuating cystic renal 
lesions on unenhanced CT examinations [5; 6]. In general, cystic renal lesions 
measuring between 20 – 40 HU may be considered proteinaceous cysts. In case of 
attenuation values of 40 – 50 HU the lesions content may be of haemorrhagic origin 
[7]. These homogeneously hyperattenuating, non – enhancing cystic renal lesions 
are considered benign and classified category II by Bosniak [1]. Therefore follow-up 
CT examinations are not required.  
 On contrast-enhanced single-energy CT images, haemorrhagic or 
proteinaceous contents as well as contrast enhancement may be responsible for an 
increase in attenuation value of a cystic renal lesion’s content. However, unless 
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 additional unenhanced CT is performed, contrast agent uptake cannot be determined 
or ruled-out reliably. Furthermore, the differentiation between haemorrhagic and 
proteinaceous cystic renal lesions is currently not possible with standard, single-
energy CT acquisition techniques [5; 7]. However, this differentiation might be of 
interest in order to differentiate renal cell carcinomas from haemorrhagic or 
inflammatory renal cysts.   
 The purpose of this study was to assess the performance of dual-energy CT 
(DECT) equipped with a new tin filter technology to differentiate renal cyst proxies 
containing protein, blood, iodinated contrast agent or saline solution in an 
experimental phantom study setup. 
 4
 Materials and Methods 
 
Kidney phantom  
A hollow acrylic elliptic sphere (120 x 65 x 65 mm) served as a kidney 
phantom. In a first benchmark model, the phantom was filled with minced beef mixed 
with distilled water to simulate unenhanced renal parenchyma (unenhanced kidney 
phantom). In a second benchmark model, the phantom was filled with minced beef 
mixed with iodinated contrast agent (Ultravist, 300 mg iodine/mL, Bayer Schering 
Pharma, Berlin, Germany) to a mean CT attenuation of 250 HU as measured at 120 
kV single-energy CT to simulate contrast-enhanced renal parenchyma in the 
nephrographic phase (contrast-enhanced kidney phantom). 
 
Cystic renal lesion proxies 
Seventy spherical proxies were manufactured from rubber gloves and 
randomly filled with either sterile saline, fresh human blood, bovine serum albumine 
or iodinated contrast agent solutions: 
 
 10 proxies filled with sterile saline solution resulting in a mean CT attenuation 
value of 0 HU simulating simple renal cysts; 
 
 20 proxies filled with iodinated contrast medium (Ultravist, 300 mg iodine/mL, 
Bayer Schering Pharma, Berlin, Germany) titrated with distilled water to 
concentrations of 0.9mg (n=10) and 1.8mg (n=10) iodine / ml and mean CT 
attenuation values of 20 and 40 HU simulating renal mass lesions with different 
degrees of attenuation; 
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  20 proxies filled with bovine serum albumine (Cohn Fraction V, ≥96% purified 
lyophilized powder, Sigma Aldrich Co., St. Louis MO, USA) titrated with distilled 
water to mean CT attenuation values of 20 and 40 HU simulating proteinaceous 
renal cysts with different degrees of attenuation; 
  
 20 proxies filled with fresh human blood titrated with distilled water to mean CT 
attenuation values of 20 and 40 HU simulating complicated haemorrhagic renal 
cysts with different degrees of attenuation. 
 
The CT attenuation of all titrated solutions was determined by mean CT 
attenuation value measurements upon single-energy CT images of each lesion proxy 
in the kidney phantom using the following CT acquisition parameters: collimation 64 x 
0.6 mm, slice acquisition 128 x 0.6 mm by means of a z-flying focal spot, tube 
voltage 120 kV, tube current-time product 200 mAs, pitch 0.35, and rotation time 0.33 
s. Images of this acquisition were reconstructed to a slice thickness of 1.0 mm at a 




Each ten cystic renal lesion proxies titrated to different CT attenuation values 
(i.e. 20 HU and 40 HU) were randomly placed inside the kidney phantom ensuring 
that each proxy was completely surrounded by minced beef and was neither in 
contact with another proxy nor with the wall of the phantom. A radiologist not involved 
in data analysis noted the position of each renal proxy and its content. The 
assembled kidney phantom was submerged in a 28-cm tank filled with distilled water 
to simulate surrounding body attenuation. The water tank was then examined using a 
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 second-generation 128-slice dual-source CT system (SOMATOM Definition Flash, 
Siemens Healthcare, Forchheim, Germany) operated using two different protocols: 
 
 Protocol A: Tube voltage pair of 140 kV and 80 kV with tube current time 
products of 56 mAs and 308 mAs, respectively, no tin filtering. 
 Protocol B: Tube voltage pair of 140 kV and 80 kV with tube current time 
products of 140 mAs and 333 mAs and tin filtering of the 140 kV tube. 
 
For DECT, the tube currents were adjusted to yield constancy in CT volume 
dose index of 9.0 mGy for both protocols. The CT acquisition parameters were: 
collimation, 32 x 0.6 mm, slice acquisition, 64 x 0.6 mm by means of a z-flying focal 
spot, pitch, 0.35, and gantry rotation time, 0.5 s. All image data was reconstructed to 
a slice thickness of 1.0 mm at a reconstruction increment of 0.7 mm using a soft 
tissue convolution kernel specifically designed for DECT (D30). 
All images of the DECT acquisitions of the unenhanced and contrast-
enhanced phantom were reformatted displaying only a single proxy at a time for both 
protocols (i.e. with and without tin-filtering) and energy spectra (i.e. 80kV and 140kV). 
All text annotations were removed from all images by a radiologist not involved in 
data analysis.  
 
CT data analysis 
A radiologist not involved in further data analysis measured the size of each 
lesion proxy using an electronic calliper tool. The anonymised dual-energy images 
were displayed in random order to two radiologists experienced in genitourinary 
imaging. Both observers (Reader 1, R1, 4 years of genitourinary cross-sectional 
image interpretation experience; and Reader 2, R2, 3 years of experience) were 
blinded to each other and independently performed a quantitative analysis of the CT 
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 attenuation values by placing a region of interest inside each proxy. Each observer 
repeated the measurement within a time interval of 2 weeks in a second data 
analysis session. The standard deviation of the mean CT attenuation value in each 
lesion was noted and considered to define image noise. 
 
Statistical Analysis 
All statistical analysis was performed using commercially available software 
(SPSS, release 17.0, Chicago, IL, USA). A p-level < 0.05 was considered to indicate 
statistical significance. 
Categorical variables were expressed as frequencies and percentages. 
Numerical variables were expressed as means ± standard deviations. Kruskal Wallis 
analysis was performed to test for differences in lesion proxy size among the different 
groups. Inter- and intra-observer agreements concerning measurement of CT 
attenuation values within the lesion proxies were assessed using Pearson’s analysis. 
The ratio of the mean CT attenuation values between 80 kV and 140 kV (i.e. 80/140 
ratio; DE-Ratio) was calculated for each setting. CT attenuation values and DE-ratios 




Cystic renal lesion proxies’ characteristics 
The average size of all lesion proxies (i.e. 20 ± 3 mm; range, 14 – 28 mm) was 
similar (p = 0.29) for different concentrations (i.e. 20 HU and 40 HU) and contents.  
 
Intraobserver and interobserver agreements 
Intra- (R1, r = 0.97; p < 0.001; R2, r = 0.95; p < 0.001) and interobserver (r = 
0.93; p < 0.001) agreements for all CT attenuation value measurements were 
excellent. Thus, the average of CT attenuation value measurements of both readers 
and both image analysis sessions were used for further statistical analysis. 
 
Quantitative measurements of the proxies’ contents 
A summary of the quantitative analysis of the CT attenuation values in both 
protocols (i.e. with and without tin filtering) and kidney phantoms (i.e. contrast-
enhanced and unenhanced) is provided in Tables 1 and 2. 
 
Comparison of results between both phantoms  
 In the contrast-enhanced phantom, all CT attenuation values were significantly 
higher than in the unenhanced phantom (average increase, 12.5 ± 3.6 HU; p < 0.05) 
in both energy spectra (i.e. 80 kV and 140 kV) with and without tin filtering. There 
was no significant difference in DE-ratios of the protein-, blood-, and contrast-




 Unenhanced kidney phantom  
Comparing protein-, blood-, and contrast-containing proxies, the CT 
attenuation values were significantly different at 140 kV (each, p < 0.01) and 80 kV 
(each, p < 0.05), with and without tin filtering (Fig. 1).  
There was a significant difference of the CT attenuation values of protein-, 
blood-, and contrast-containing proxies between 80 kV and 140 kV with tin filtering 
(each, p < 0.05) and for contrast-containing proxies without tin filtering (p < 0.01), 
while no significant difference was found for protein- (p = 0.74) and blood-containing 
proxies (p = 0.38) without tin filtering between 80 kV and 140 kV. With the use of a tin 
filter, the DE-ratios were significantly different for protein-containing proxies (p < 0.01, 
Table 1) when compared to the non-tin filtered acquisition. 
 
Contrast-enhanced kidney phantom 
The CT attenuation values of protein-, blood-, and contrast-containing proxies 
were significantly different at 80 kV (each, p < 0.05) and 140 kV (each, p < 0.01, Fig. 
1), with and without tin filtering.  
There was a significant difference of the CT attenuation values between 80 kV 
and 140 kV for protein-, blood-, and contrast-containing proxies with tin filtering 
(each, p < 0.01) as well as for contrast-containing proxies without tin filtering (p < 
0.01). No significant difference was found for protein- (p = 0.21) and blood-containing 
proxies (p = 0.08) between 80 kV and 140 kV. With and without tin filtering, the DE-





 Image noise 
The image noise was significantly lower in the tin-filtered acquisitions (16 ± 1 
HU) when compared to the non-tin-filtered acquisitions (18 ± 1 HU; p < 0.05). 
 
Discrimination of protein, blood and contrast agent  
Without the application of tin filtering, the DE-ratios for protein- and blood- 
containing proxies were significantly different from the DE-ratios of contrast 
containing proxies in the unenhanced  (Fig. 2a) and contrast-enhanced phantom 
(each, p < 0.05; Fig. 2b). There was no significant difference in the DE-ratios between 
protein- and blood- containing proxies in the unenhanced (p = 0.79; Fig. 2a) and 
contrast-enhanced kidney phantom (p = 0.29; Fig. 2b). 
With the application of tin filtering, the DE-ratios for protein- and blood- 
containing proxies were significantly different from the DE-ratios of contrast 
containing proxies in the unenhanced (Fig. 2c) and contrast-enhanced kidney 
phantom (each, p < 0.05; Fig. 2d). The DE-ratios between protein- and blood- 
containing proxies were significantly different in the unenhanced (p < 0.05; Fig. 2c) 




 The purpose of this study was to discriminate cystic renal lesion proxies with 
different contents using DECT with a new tin filtering technology. Our results have 
shown, that a differentiation between contrast material containing cystic renal lesion 
proxies and protein- or blood- containing cystic renal lesion proxies is feasible using 
80 /140 kV ratios calculated from DECT data. Further on we were able to 
discriminate protein- from blood containing cystic renal lesion proxies by using an 
additional tin filter. 
In the early 1970s, DECT had been introduced for material decomposition 
making use of attenuation characteristics of different materials at two different X-ray 
energy spectra [8]. The recent introduction of dual-source CT (DSCT) systems has 
re-enlivened DECT for various clinical indications [9-17], owing to the simultaneous 
data acquisition of two X-ray tube-detector systems at two different X-ray spectra.  
Common applications of DECT include the reconstruction of virtual unenhanced 
images to spare the (true) unenhanced CT acquisition and therefore reduce the total 
radiation dose [9-12], the detailed use of material decomposition techniques to 
characterise urinary stones of different compositions [9; 13-16], the separation of 
xenon from air [18], or blood from air [19; 20].   
Recently, the second generation of DSCT systems - equipped with a new tin 
filter technology for increased X-ray energy spectra separation [17] - was introduced. 
These tin filters, mounted on the 140kV tube, have been suggested, but not proven 
to further improve the differentiation of material sharing overlapping attenuation 
values at single-energy CT examinations. Very recently an improved differentiation of 
urinary calculi has been reported using tin filtered dual-energy CT [21; 22]. 
Additionally, Leschka et al. were able to differentiate renal cysts from contrast-
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 enhancing renal mass lesions by applying the tin filter technology to dual-energy CT 
[23] and Graser et al. have reported an added value of tin-filtered DECT when 
determining the dignity of renal lesions [24].           
The classification of renal cysts using abdominal CT primarily relies on their 
attenuation behaviour on unenhanced images and on their enhancement pattern 
after the administration of intravenous iodinated contrast agent. However, most cystic 
renal lesions are discovered incidentally on contrast-enhanced abdominal CT 
examinations performed for non-renal indications [1] and in case of equivocal 
findings regarding their attenuation on contrast-enhanced CT studies, patients may 
need to be recalled to undergo a second, unenhanced abdominal CT, a procedure 
causing increased costs and radiation exposure to the patient. Moreover, the 
assessment of enhancement of cystic renal lesions may be prone to errors by 
erroneously assuming a “true” enhancement in the presence of the - so called - 
pseudoenhancement, which refers to an artificial increase in attenuation of a simple 
renal cyst following contrast agent application, and is most problematic for small 
cysts at high levels of renal parenchymal enhancement (8, 9). This issue is further 
complicated by the fact that certain renal cell carcinomas may enhance in a rather 
weak and homogeneous manner [25]. Pseudoenhancement thus may lead to 
mischaracterization of a small renal cyst as a neoplasm eventually leading to 
unnecessary interventions. We found higher CT attenuation values in the contrast-
enhanced kidney phantom compared to the unenhanced phantom, due to this 
pseudoenhancement. Interestingly, the dual-energy ratios for blood-, protein-, and 
contrast-containing cystic renal lesion proxies were similar in both phantoms. 
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  The principle of DECT bases on the varying attenuations of different materials 
at two different X-ray energy spectra [9-11; 13-15; 17]. In a recent study, the ability of 
DECT (without tin filter technology) to discriminate renal cysts from iodine containing 
renal masses was shown, with a sensitivity of 97% and specificity of 83% [26]. Our 
study confirms and extends those results by demonstrating the feasibility of DECT to 
differentiate proteinaceous or haemorrhagic from contrast containing cystic renal 
lesion proxies by means of their different attenuation behaviour at 140kV and 80kV. 
We found that the DE-ratios of protein- or blood- containing proxies differ significantly 
from the DE-ratios of contrast-containing proxies. Consequently, DECT allows for the 
discrimination of protein- or blood- containing cystic renal lesion proxies from 
contrast-containing proxies. Therefore, additional unenhanced CT need not be 
performed. Our study also demonstrates that a further discrimination between 
proteinaceous and haemorrhagic proxies is feasible when applying a tin filter. 
Without this tin filter, a substantial overlap in the CT attenuation values measured at 
140kV and 80kV was found between protein- and blood- containing proxies. This 
may be explained by the suboptimal separation of X-ray energy spectra without the 
use of a tin filter which is particularly important for material with only minor 
differences in X-ray absorption [14]. The tin filter reduces overlap in X-ray energy 
spectra by increasing the mean photon energy of the 140 kV-tube and, therefore, 
improves both material differentiation and decomposition [17]. As a matter of fact, we 
found different DE-ratios between the attenuation values measured at 140kV and 
80kV for proteinaceous cysts with or without the application of the tin filter. 
Consequently, a significantly different DE-ratio between protein- and blood- 
containing proxies was found in the protocol applying the tin filter allowing for the 
discrimination of these contents. 
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 Albeit the phantom used in our study was designed to simulate optimal 
conditions comparable to in-vivo abdominal CT, we have to acknowledge some 
limitations. This is a phantom study, and therefore the performance of DECT for 
discriminating protein, blood, and lesions containing contrast agent needs to be 
validated in further clinical studies. Furthermore, we assumed albumin to be the main 
component in proteinaceous renal cysts. The real content of proteinaceous cysts 
might vary from patient to patient and may depend on a possible underlying 
pathology. Therefore, the DE-ratios in clinical abdominal CT might differ from our 
results, and a larger overlap of the CT attenuation values measured at 140 kV and 80 
kV between protein and blood content might limit the discrimination of proteinaceous 
and haemorrhagic cysts in clinical practice. However, we have chosen albumin 
because it is highly available in purified condition, and, therefore, easy to handle in 
experimental settings. Another limitation may be the size of the kidney phantom. With 
a diameter of 28cm, a comparison to human bodies is not possible. The attenuation 
values of cystic renal lesions may vary in vivo. Another option for dual-energy CT in 
vivo is the use of a 140 kV / 100 kV protocol, which may be helpful especially in 
obese patients.  
 
Conclusion 
  In conclusion, DECT is able to discriminate proteinaceous or haemorrhagic 
cystic renal lesion proxies from cystic renal lesion proxies containing contrast agent 
through their different attenuation behaviour at 140kV and 80kV. Applying the tin filter 
technology to DECT allows for a further discrimination of protein and blood content 
within the cystic renal lesion proxies. 
 Tables 
 
Table 1 Quantitative analysis of the proxies’ CT attenuation values in the unenhanced kidney phantom. 
 
 Protocol A – Tin Filter OFF Protocol B – Tin Filter ON 
 *NCT 120 kV *NCT 80 kV *NCT 140 kV Ratio 80/140  *NCT 80 kV #SN *NCT 140 kV SN Ratio 80/140 SN 
p values † 
Saline  0 2.5 ± 1.7 2.5 ± 1.1 1.1 ± 1.1 2.1 ± 2.1 2.5 ± 1.8 1.2 ± 0.8 0.72 
20 16.9 ± 1.4 16.8 ± 1.5 1.0 ± 0.1 14.3 ± 2.4 18.4 ± 1.3 0.8 ± 0.1 <0.01 
Protein  
40 39.0 ± 1.4 38.8 ± 1.7 1.0 ± 0.1 34.9 ± 2.5 43.7 ± 2.0 0.8 ± 0.1 <0.01 
20 20.0 ± 1.1 18.3 ± 2.8 1.1 ± 0.2 21.7 ± 1.9 17.5 ± 1.2 1.2 ± 0.1 0.12 
Blood  
40 35.9 ± 2.0 33.5 ± 2.1 1.1 ± 0.1 37.7 ± 3.3 33.7 ± 2.3 1.1 ± 0.1 0.38 
20 25.2 ± 1.4 12.0 ± 1.0 2.1 ± 0.2 20.9 ± 1.4 10.7 ± 0.8 2.0 ± 0.2 0.48 
Contrast medium 
40 46.5 ± 1.5 24.1 ± 2.0 2.0 ± 0.1 42.3 ± 2.2 18.8 ± 1.3 2.2 ± 0.3 0.06 
 
† p values are derived from statistical comparison of the different ratios between CT attenuation values measured at 80kV and 140kV between protocol A and 
protocol B (Wilcoxon paired sample test) 
* CT attenuation value measurement in Hounsfield units (HU) 
# SN = tin filter 
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Table 2 Quantitative analysis of the proxies’ CT attenuation values in the contrast enhanced kidney phantom. 
 
 Protocol A – Tin Filter OFF Protocol B – Tin Filter ON 
 *NCT 120 kV *NCT 80 kV *NCT 140 kV Ratio 80/140  *NCT 80 kV #SN *NCT 140 kV SN Ratio 80/140 SN 
p values † 
Saline  0 12.2 ± 2.8 10.8 ± 2.7 1.1 ± 0.2 13.1 ± 2.9 10.8 ± 3.8 1.2 ± 0.5 0.53 
20 32.9 ± 6.4 32.9 ± 5.9 1.0 ± 0.1 22.4 ± 2.6 31.3 ± 5.0 0.7 ± 0.1 <0.01 
Protein  
40 48.8 ± 2.8 51.0 ± 2.0 1.0 ± 0.1 41.9 ± 3.0 50.2 ± 5.9 0.8 ± 0.1 <0.01 
20 33.7 ± 4.8 28.9 ± 3.3 1.2 ± 0.2 34.4 ± 2.8 25.4 ± 3.1 1.4 ± 0.1 0.07 
Blood  
40 51.0 ± 4.8 44.2 ± 4.0 1.2 ± 0.1 49.3 ± 3.3 37.9 ± 3.6 1.3 ± 0.1 0.23 
20 45.9 ± 6.0 23.2 ± 2.0 2.0 ± 0.3 36.9 ± 3.9 18.4 ± 3.0 2.0 ± 0.2 0.47 
Contrast medium 
40 59.5 ± 2.6 31.9 ± 2.2 1.9 ± 0.2 57.7 ± 2.6 27.5 ± 1.9 2.1 ± 0.2 0.19 
 
† p values are derived from statistical comparison of the different ratios between CT attenuation values measured at 80kV and 140kV between protocol A and 
protocol B (Wilcoxon paired sample test) 
* CT attenuation value measurement in Hounsfield units (HU) 





 Figures  
Fig. 1 – Imaging examples of renal cyst proxies containing blood, contrast media, 
saline solution, and protein at single-energy CT (120 kV) and dual-energy CT with 
and without tin filtering in the unenhanced and contrast-enhanced kidney phantom. 
Note the difference in attenuation of the cysts and the contrast-enhanced minced 





 Fig. 2a 
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 Fig. 2b 
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 Fig. 2 – Dual-energy ratio of the CT attenuation value at 80 kV / 140 kV for protein, 
blood, and contrast-containing lesion proxies without tin filtering in the unenhanced 
(Fig. 2a) and contrast-enhanced kidney phantom (Fig. 2b); and with tin filtering in the 
unenhanced (Fig. 2c) and contrast-enhanced kidney phantom (Fig. 2d). With and 
without tin filtering, the 80 / 140 kV ratios of protein and blood-containing proxies 
were significantly different from that of the contrast-containing proxies in the 
unenhanced and contrast-enhanced kidney phantom (each, p < 0.05). Without tin 
filtering (Fig. 2a,b), there was no significant difference in the 80 / 140 kV ratios 
between protein and blood-containing lesions, while the 80 / 140 kV ratios were 
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